AN2 Therapeutics Inc Form 4 Filed on July 10

AN2 Therapeutics Inc (ANTX) filed a Form 4 on July 10, detailing insider trading activities. The filing included transactions by certain executives, which are required disclosures of changes in ownership. Such filings can affect investor perception and trading volumes. This information is important for investors as it may indicate management's confidence in the company's future performance.